Gene Therapy
High-Yield Trend
Questions 5 MCQs
The genetic defect-Adenosine Deaminase (ADA) deficiency may be cured permanently by:
| 1. | periodic infusion of genetically engineered lymphocytes having functional ADA cDNA |
| 2. | administering adenosine deaminase activators |
| 3. | introducing bone marrow cells producing ADA into cells at early embryonic stages |
| 4. | invitro cell culture therapy |
Which kind of therapy was given in 1990 to a four-year-old girl with Adenosine Deaminase (ADA) deficiency?
1. Gene therapy
2. Chemotherapy
3. Immunotherapy
4. Radiation therapy
2. Ti plasmid
3. \lambda phage
4. pBR 322
When gene targeting involving gene amplification is attempted in an individual's tissue to treat disease, it is known as:
| 1. | Molecular diagnosis | 2. | Safety testing |
| 3. | Biopiracy | 4. | Gene therapy |
| 1. | Genetically engineered lymphocytes are not immortal cells. |
| 2. | Retroviral vector is introduced into these lymphocytes. |
| 3. | Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stages |
| 4. | Lymphocytes from patient's blood are grown in culture, outside the body. |
Preparing Gene Therapy for NEET
Gene Therapy is a specific sub-topic that frequently appears in the NEET examination. Understanding the underlying principles and practicing targeted questions is key to mastering this concept.
The questions compiled above are previous year questions (PYQs) directly related to Gene Therapy. Practicing these specific questions helps you understand the difficulty level and the examiner's approach to this topic.
Topic Frequently Asked Questions
Is Gene Therapy a high-weightage topic?
You can refer to the priority and consistency badges at the top of this page. High priority topics should be thoroughly revised multiple times before the exam.
Should I memorize the solutions?
No, it is highly recommended to understand the core concept and methodology behind each solution rather than memorizing them, as exact questions are rarely repeated, but the concepts definitely are.